TPO
Basic information
Region (hg38): 2:1374066-1543711
Links
Phenotypes
GenCC
Source:
- thyroid dyshormonogenesis 2A (Strong), mode of inheritance: AR
- familial thyroid dyshormonogenesis (Supportive), mode of inheritance: AR
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
Thyroid dyshormonogenesis 2A | AR | Endocrine; Oncologic | Medical treatment of hypothyroidism (eg, with T4) can be effective; Thyroid neoplasms have also been reported, and surveillance may be beneficial | Endocrine; Oncologic | 1401057; 8027236; 9814507; 10084596 |
ClinVar
This is a list of variants' phenotypes submitted to
- not provided (51 variants)
- Deficiency of iodide peroxidase (17 variants)
- Neurodevelopmental disorder (1 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the TPO gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 272 | 12 | 285 | |||
missense | 14 | 81 | 120 | |||
nonsense | 18 | 19 | ||||
start loss | 0 | |||||
frameshift | 26 | 29 | ||||
inframe indel | 4 | |||||
splice donor/acceptor (+/-2bp) | 12 | 12 | ||||
splice region | 1 | 4 | 32 | 2 | 39 | |
non coding | 12 | 116 | 38 | 166 | ||
Total | 53 | 30 | 96 | 397 | 59 |
Highest pathogenic variant AF is 0.000118
Variants in TPO
This is a list of pathogenic ClinVar variants found in the TPO region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
2-1412635-T-C | Uncertain significance (Nov 11, 2022) | |||
2-1413472-A-G | Deficiency of iodide peroxidase | Benign (Jan 12, 2018) | ||
2-1413478-C-T | Deficiency of iodide peroxidase | Uncertain significance (Jan 13, 2018) | ||
2-1413496-C-T | Deficiency of iodide peroxidase | Uncertain significance (Jan 12, 2018) | ||
2-1413537-G-C | Deficiency of iodide peroxidase | Uncertain significance (Apr 27, 2017) | ||
2-1413564-T-C | Deficiency of iodide peroxidase | Uncertain significance (Jan 12, 2018) | ||
2-1414397-G-A | Deficiency of iodide peroxidase | Uncertain significance (Apr 27, 2017) | ||
2-1414416-C-T | Likely benign (Jan 31, 2024) | |||
2-1414417-G-A | Deficiency of iodide peroxidase | Conflicting classifications of pathogenicity (Jan 05, 2024) | ||
2-1414417-G-T | Likely benign (Dec 19, 2023) | |||
2-1414420-C-G | not specified • Deficiency of iodide peroxidase | Benign (Feb 01, 2024) | ||
2-1414420-C-T | Deficiency of iodide peroxidase | Conflicting classifications of pathogenicity (Dec 19, 2023) | ||
2-1414429-G-A | Likely benign (Sep 22, 2023) | |||
2-1414438-G-A | Deficiency of iodide peroxidase • not specified | Conflicting classifications of pathogenicity (Jan 31, 2024) | ||
2-1414439-C-T | Likely benign (Sep 05, 2023) | |||
2-1414438-G-GCTGGTTATGGCCTGCACAGA | Deficiency of iodide peroxidase | Pathogenic (Sep 09, 2023) | ||
2-1414446-T-C | Inborn genetic diseases | Uncertain significance (Jan 09, 2024) | ||
2-1414455-C-A | Inborn genetic diseases | Uncertain significance (Mar 21, 2023) | ||
2-1414455-C-T | Inborn genetic diseases | Uncertain significance (Apr 15, 2024) | ||
2-1414479-C-T | Inborn genetic diseases | Likely benign (May 14, 2024) | ||
2-1414480-G-A | Likely benign (Dec 26, 2023) | |||
2-1414486-G-A | Likely benign (Oct 29, 2023) | |||
2-1414489-A-G | Likely benign (Dec 29, 2023) | |||
2-1414509-A-G | Likely benign (Nov 26, 2023) | |||
2-1414510-G-A | Likely benign (Jul 24, 2023) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
TPO | protein_coding | protein_coding | ENST00000345913 | 16 | 169489 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
1.82e-21 | 0.0210 | 125581 | 0 | 167 | 125748 | 0.000664 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.00335 | 567 | 567 | 1.00 | 0.0000398 | 5971 |
Missense in Polyphen | 183 | 196.02 | 0.93359 | 2236 | ||
Synonymous | -0.865 | 276 | 258 | 1.07 | 0.0000213 | 1938 |
Loss of Function | 0.980 | 36 | 42.9 | 0.839 | 0.00000226 | 459 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.00125 | 0.00124 |
Ashkenazi Jewish | 0.00139 | 0.00139 |
East Asian | 0.00191 | 0.00190 |
Finnish | 0.0000463 | 0.0000462 |
European (Non-Finnish) | 0.000617 | 0.000615 |
Middle Eastern | 0.00191 | 0.00190 |
South Asian | 0.000657 | 0.000653 |
Other | 0.000327 | 0.000326 |
dbNSFP
Source:
- Function
- FUNCTION: Iodination and coupling of the hormonogenic tyrosines in thyroglobulin to yield the thyroid hormones T(3) and T(4). {ECO:0000250|UniProtKB:P09933}.;
- Disease
- DISEASE: Note=An alternative splicing in the thyroperoxidase mRNA can cause Graves' disease.; DISEASE: Thyroid dyshormonogenesis 2A (TDH2A) [MIM:274500]: A disorder due to defective conversion of accumulated iodide to organically bound iodine. The iodide organification defect can be partial or complete. {ECO:0000269|PubMed:10084596, ECO:0000269|PubMed:10468986, ECO:0000269|PubMed:11061528, ECO:0000269|PubMed:11415848, ECO:0000269|PubMed:11874711, ECO:0000269|PubMed:11916616, ECO:0000269|PubMed:12213873, ECO:0000269|PubMed:12490071, ECO:0000269|PubMed:12843174, ECO:0000269|PubMed:12864797, ECO:0000269|PubMed:12938097, ECO:0000269|PubMed:16284446, ECO:0000269|PubMed:16684826, ECO:0000269|PubMed:27305979, ECO:0000269|PubMed:7550241, ECO:0000269|PubMed:9024270, ECO:0000269|PubMed:9924196}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
- Pathway
- Thyroid hormone synthesis - Homo sapiens (human);Autoimmune thyroid disease - Homo sapiens (human);Tyrosine metabolism - Homo sapiens (human);Thyroid hormone synthesis;Thyroxine (Thyroid Hormone) Production;Differentiation Pathway;Hematopoietic Stem Cell Differentiation;Development of pulmonary dendritic cells and macrophage subsets;Amino Acid metabolism;Metabolism of amino acids and derivatives;thyroid hormone biosynthesis;Tyrosine metabolism;Androgen and estrogen biosynthesis and metabolism;Purine metabolism;Metabolism;Thyroxine biosynthesis;Amine-derived hormones
(Consensus)
Recessive Scores
- pRec
- 0.482
Intolerance Scores
- loftool
- 0.854
- rvis_EVS
- -0.14
- rvis_percentile_EVS
- 42.36
Haploinsufficiency Scores
- pHI
- 0.186
- hipred
- N
- hipred_score
- 0.489
- ghis
- 0.441
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.764
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | High |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Tpo
- Phenotype
- endocrine/exocrine gland phenotype; growth/size/body region phenotype; homeostasis/metabolism phenotype; craniofacial phenotype; limbs/digits/tail phenotype; hearing/vestibular/ear phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); hematopoietic system phenotype; skeleton phenotype; immune system phenotype; vision/eye phenotype;
Gene ontology
- Biological process
- thyroid hormone generation;response to oxidative stress;embryonic hemopoiesis;hormone biosynthetic process;hydrogen peroxide catabolic process;oxidation-reduction process;cellular oxidant detoxification
- Cellular component
- extracellular space;plasma membrane;integral component of plasma membrane;cell surface
- Molecular function
- iodide peroxidase activity;peroxidase activity;calcium ion binding;heme binding